April 15, 2026 · Phase 2 readout
CALC Phase 2 readout: a positive outcome, +8.9%
On April 15, 2026, Auxora — CalciMedica, Inc. (Acute Kidney Injury) reached its Phase 2 readout. The result was a positive outcome, and the stock moved +8.9% in the window around the event. It had already run +12.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.
The move
$0.54
1d before
$0.59
Event day
$0.58
1d after
$0.62
5d after
Pre-catalyst setup
+12.2%
30-day run-up
14213%
30-day volatility
0.2×
volume spike